Genvax is a startup animal vaccine company developing next generation self amplifying mRNA vaccines for animal health.

Focused on:

• Creating rapid response saRNA vaccines to build 100% match, custom and targeted vaccines to production livestock producers in the face of endemic and emerging diseases
• Eliminating need for antiquated, expensive, ineffective vaccine stockpiles 
• Bringing advances in human healthcare into animal health

Genvax has a dynamic team of experienced scientists and entrepreneurs.